↓ Skip to main content

Implications of disease-modifying therapies for multiple sclerosis on immune cells and response to COVID-19 vaccination

Overview of attention for article published in Frontiers in immunology, July 2024
Altmetric Badge

Mentioned by

twitter
1 X user

Readers on

mendeley
2 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Implications of disease-modifying therapies for multiple sclerosis on immune cells and response to COVID-19 vaccination
Published in
Frontiers in immunology, July 2024
DOI 10.3389/fimmu.2024.1416464
Pubmed ID
Authors

Valeria Orrù, Valentina Serra, Michele Marongiu, Sandra Lai, Valeria Lodde, Magdalena Zoledziewska, Maristella Steri, Annalisa Loizedda, Monia Lobina, Maria Grazia Piras, Francesca Virdis, Giuseppe Delogu, Maria Giuseppina Marini, Maura Mingoia, Matteo Floris, Marco Masala, M. Paola Castelli, Rafaela Mostallino, Jessica Frau, Lorena Lorefice, Gabriele Farina, Marzia Fronza, Daniele Carmagnini, Elisa Carta, Silvy Pilotto, Paola Chessa, Marcella Devoto, Paolo Castiglia, Paolo Solla, Roberto Ignazio Zarbo, Maria Laura Idda, Maristella Pitzalis, Eleonora Cocco, Edoardo Fiorillo, Francesco Cucca

X Demographics

X Demographics

The data shown below were collected from the profile of 1 X user who shared this research output. Click here to find out more about how the information was compiled.
As of 1 July 2024, you may notice a temporary increase in the numbers of X profiles with Unknown location. Click here to learn more.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 2 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 2 100%

Demographic breakdown

Readers by professional status Count As %
Researcher 2 100%
Readers by discipline Count As %
Medicine and Dentistry 2 100%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 1. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 16 July 2024.
All research outputs
#23,797,834
of 26,491,397 outputs
Outputs from Frontiers in immunology
#28,817
of 33,329 outputs
Outputs of similar age
#192,757
of 245,580 outputs
Outputs of similar age from Frontiers in immunology
#389
of 707 outputs
Altmetric has tracked 26,491,397 research outputs across all sources so far. This one is in the 1st percentile – i.e., 1% of other outputs scored the same or lower than it.
So far Altmetric has tracked 33,329 research outputs from this source. They typically receive more attention than average, with a mean Attention Score of 8.6. This one is in the 1st percentile – i.e., 1% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 245,580 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 1st percentile – i.e., 1% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 707 others from the same source and published within six weeks on either side of this one. This one is in the 1st percentile – i.e., 1% of its contemporaries scored the same or lower than it.